[Topical Dibekacin therapy of experimental Pseudomonas keratitis (author's transl)].
D000287:Administration, Topical; D000818:Animals; D003982:Dibekacin / Q000008:administration & dosage* / Q000627:therapeutic use; D006168:Guinea Pigs; D007612:Kanamycin / Q000031:analogs & derivatives*; D007634:Keratitis / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011552:Pseudomonas Infections / Q000188:drug therapy*
D009883:Ophthalmic Solutions; D003982:Dibekacin; D007612:Kanamycin